291 related articles for article (PubMed ID: 15939202)
1. Behavioral test methods workshop.
Slikker W; Acuff K; Boyes WK; Chelonis J; Crofton KM; Dearlove GE; Li A; Moser VC; Newland C; Rossi J; Schantz S; Sette W; Sheets L; Stanton M; Tyl S; Sobotka TJ
Neurotoxicol Teratol; 2005; 27(3):417-27. PubMed ID: 15939202
[TBL] [Abstract][Full Text] [Related]
2. Procedures and methods of benefit assessments for medicines in Germany.
Bekkering GE; Kleijnen J
Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
[TBL] [Abstract][Full Text] [Related]
3. [Procedures and methods of benefit assessments for medicines in Germany].
Bekkering GE; Kleijnen J
Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
[TBL] [Abstract][Full Text] [Related]
4. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
5. Strategy for genotoxicity testing: hazard identification and risk assessment in relation to in vitro testing.
Thybaud V; Aardema M; Clements J; Dearfield K; Galloway S; Hayashi M; Jacobson-Kram D; Kirkland D; MacGregor JT; Marzin D; Ohyama W; Schuler M; Suzuki H; Zeiger E;
Mutat Res; 2007 Feb; 627(1):41-58. PubMed ID: 17126066
[TBL] [Abstract][Full Text] [Related]
6. Integrating epidemiology and toxicology in neurotoxicity risk assessment.
Boyes WK; Moser VC; Geller AM; Benignus VA; Bushnell PJ; Kamel F
Hum Exp Toxicol; 2007 Apr; 26(4):283-93. PubMed ID: 17615109
[TBL] [Abstract][Full Text] [Related]
7. Issues in the design and interpretation of chronic toxicity and carcinogenicity studies in rodents: approaches to dose selection.
Rhomberg LR; Baetcke K; Blancato J; Bus J; Cohen S; Conolly R; Dixit R; Doe J; Ekelman K; Fenner-Crisp P; Harvey P; Hattis D; Jacobs A; Jacobson-Kram D; Lewandowski T; Liteplo R; Pelkonen O; Rice J; Somers D; Turturro A; West W; Olin S
Crit Rev Toxicol; 2007; 37(9):729-837. PubMed ID: 17957539
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a training program for device operators in the Australian Government's Point of Care Testing in General Practice Trial: issues and implications for rural and remote practices.
Shephard MD; Mazzachi BC; Watkinson L; Shephard AK; Laurence C; Gialamas A; Bubner T
Rural Remote Health; 2009; 9(3):1189. PubMed ID: 19689171
[TBL] [Abstract][Full Text] [Related]
9. In vivo erythrocyte micronucleus assay III. Validation and regulatory acceptance of automated scoring and the use of rat peripheral blood reticulocytes, with discussion of non-hematopoietic target cells and a single dose-level limit test.
Hayashi M; MacGregor JT; Gatehouse DG; Blakey DH; Dertinger SD; Abramsson-Zetterberg L; Krishna G; Morita T; Russo A; Asano N; Suzuki H; Ohyama W; Gibson D;
Mutat Res; 2007 Feb; 627(1):10-30. PubMed ID: 17157053
[TBL] [Abstract][Full Text] [Related]
10. Collaborative Behavioral Teratology Study: implications, current applications and future directions.
Kimmel CA; Buelke-Sam J; Adams J
Neurobehav Toxicol Teratol; 1985; 7(6):669-73. PubMed ID: 3835466
[TBL] [Abstract][Full Text] [Related]
11. Undertaking positive control studies as part of developmental neurotoxicity testing: a report from the ILSI Research Foundation/Risk Science Institute expert working group on neurodevelopmental endpoints.
Crofton KM; Foss JA; Hass U; Jensen KF; Levin ED; Parker SP
Neurotoxicol Teratol; 2008; 30(4):266-87. PubMed ID: 17681747
[TBL] [Abstract][Full Text] [Related]
12. A qualitative retrospective analysis of positive control data in developmental neurotoxicity studies.
Crofton KM; Makris SL; Sette WF; Mendez E; Raffaele KC
Neurotoxicol Teratol; 2004; 26(3):345-52. PubMed ID: 15113596
[TBL] [Abstract][Full Text] [Related]
13. Animal models of obsessive-compulsive disorder: rationale to understanding psychobiology and pharmacology.
Korff S; Harvey BH
Psychiatr Clin North Am; 2006 Jun; 29(2):371-90. PubMed ID: 16650714
[TBL] [Abstract][Full Text] [Related]
14. Regulatory developmental neurotoxicity and human risk assessment.
Francis EZ
Neurotoxicology; 1992; 13(1):77-84. PubMed ID: 1508435
[TBL] [Abstract][Full Text] [Related]
15. Alternative methods to safety studies in experimental animals: role in the risk assessment of chemicals under the new European Chemicals Legislation (REACH).
Lilienblum W; Dekant W; Foth H; Gebel T; Hengstler JG; Kahl R; Kramer PJ; Schweinfurth H; Wollin KM
Arch Toxicol; 2008 Apr; 82(4):211-36. PubMed ID: 18322675
[TBL] [Abstract][Full Text] [Related]
16. Alternative test methods in inhalation toxicology: challenges and opportunities.
Costa DL
Exp Toxicol Pathol; 2008 Jun; 60(2-3):105-9. PubMed ID: 18486462
[TBL] [Abstract][Full Text] [Related]
17. Strategy for genotoxicity testing--metabolic considerations.
Ku WW; Bigger A; Brambilla G; Glatt H; Gocke E; Guzzie PJ; Hakura A; Honma M; Martus HJ; Obach RS; Roberts S;
Mutat Res; 2007 Feb; 627(1):59-77. PubMed ID: 17141553
[TBL] [Abstract][Full Text] [Related]
18. Exception from informed consent: viewpoint of institutional review boards--balancing risks to subjects, community consultation, and future directions.
Ernst AA; Fish S
Acad Emerg Med; 2005 Nov; 12(11):1050-5. PubMed ID: 16264073
[TBL] [Abstract][Full Text] [Related]
19. The use of pharmacokinetics as an interpretive and predictive tool in chemical toxicology testing and risk assessment: a position paper on the appropriate use of pharmacokinetics in chemical toxicology.
Frantz SW; Beatty PW; English JC; Hundley SG; Wilson AG
Regul Toxicol Pharmacol; 1994 Jun; 19(3):317-37. PubMed ID: 8090955
[TBL] [Abstract][Full Text] [Related]
20. Behavioral methods in reproductive and developmental toxicology.
Chester A; Hallesy D; Andrew F
Neurobehav Toxicol Teratol; 1985; 7(6):745-52. PubMed ID: 3835476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]